TLR4 and periodontal disorder: The possibility of limiting pro-inflammatory cytokine response after disease onset, by anti-inflammatory molecules targeting TLR4-MD2, could represent a useful adjunct for the treatment of periodontal disease, in which it is important to eradicate infection but also to stem the negative effects of the LPS released by periodontopathic bacteria.